Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODYSSEY tradipitant study in severe COVID-19
2020-005526-29Phase 3Terminated
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia comparing Tradipitant with Placebo (2 arms). Primary endpoint: Percentage of responders at day 28. Started Jan 2021; status: terminated.
02
Drugs
tradipitant
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on 2020-005526-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005526-29.